- Home
- LGHL vs UPC Comparison
LGHL vs UPC Comparison
Compare LGHL & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LGHL | UPC |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | Singapore | China |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | LGHL | UPC |
|---|---|---|
| Price | $3.48 | $3.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 740.8K | 49.7K |
| Earning Date | 04-30-2024 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $19,293,003.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.32 | $2.51 |
| 52 Week High | $213.20 | $28.80 |
Technical Indicators
Market Signals| Indicator | LGHL | UPC |
|---|---|---|
| Relative Strength Index (RSI) | 49.64 | 42.71 |
| Support Level | $3.32 | $3.95 |
| Resistance Level | $8.92 | $3.85 |
| Average True Range (ATR) | 1.15 | 0.31 |
| MACD | -0.30 | -0.01 |
| Stochastic Oscillator | 2.32 | 10.68 |
Price Performance
Historical ComparisonAbout LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About UPC Universe Pharmaceuticals Inc.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.